64Cu-Tz-SarAr
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 64Cu-Tz-SarAr, covering 2025-09-04 to 2025-09-04. Get the full timeline:
Most recent: Clinical Trial Update: PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9 [Phase 1]